Skip to content

Clinical Observation on the Application of Guasha Synthetics in Primary Dysmenorrhea

Clinical Observation on the Application of Guasha Synthetics in Primary Dysmenorrhea

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2100004407
Enrollment
Unknown
Registered
2021-02-08
Start date
2021-02-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary dysmenorrhea

Interventions

Sponsors

Guangdong Provincial Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. Subjects who meet the diagnostic criteria of dysmenorrhea of blood stasis type diagnosed by traditional Chinese medicine; 2. Subjects who were diagnosed as primary dysmenorrhea by western medicine; 3. Subjects aged 18-45 years; 4. Subjects with regular menstruation in the past, with a cycle of 21-35 days; the menstrual period is 5-7 days; 5. Patients with good compliance and cooperation with follow-up during the study period; 6. For the subjects with dysmenorrhea for more than 6 months, the VAS score was more than or equal to 4; 7. Volunteers.

Exclusion criteria

Exclusion criteria: 1. Patients with uterine fibroids, adenomyosis, pelvic inflammatory diseases, pelvic blood stasis syndrome, endometriosis, etc. may cause secondary dysmenorrhea; 2. Patients with drug allergy constitution and allergic to moxa oil; 3. Patients with abnormal liver and kidney function; 4. Subjects who participated in other trials within one month; 5. Lactation, preparation for pregnancy, or pregnant women; 6. Subjects with abnormal coagulation function; 7. Subjects with skin diseases or local skin abnormalities.

Design outcomes

Primary

MeasureTime frame
COX;

Countries

China

Contacts

Public ContactHuang Qihua

Guangdong Provincial Hospital of Traditional Chinese Medicine

13710680174@126.com+86 13710680174

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026